Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02411448
Brief Title: A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)

First Submitted : April 3, 2015
First Submitted that Met QC Criteria : April 3, 2015
First Posted : April 8, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : February 12, 2019
Last Update Posted : February 15, 2019